ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank43
3Y CAGR+20.2%
5Y CAGR-17.1%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
+20.2%/yr
vs -45.8%/yr prior
5Y CAGR
-17.1%/yr
Recent acceleration
Acceleration
+66.0pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202511.87%
202431.85%
202340.45%
20226.83%
20219.60%
202030.28%
201951.50%
201879.19%
2017620.68%
201628311.48%